title: Actions of cholinergic agonists and antagonists on the efferent synapse in the frog sacculus.
abstract: Intracellular recordings were made from hair cells in the frog saccular epithelium isolated with its innervating nerves. Inhibitory post-synaptic potentials (IPSPs) were recorded from hair cells when the efferent fibers were activated by electrical stimulation. The effects of acetylcholine (ACh), cholinomimetics, and cholinergic antagonists on the efferent synapse were studied in a preparation where the IPSPs can be observed directly. ACh or carbachol (CCh) produced a transient membrane hyperpolarization with a decrease in input resistance followed by an abolition or reduction of the IPSP. In a low Ca2+ medium where efferent synaptic activity was abolished, ACh or CCh still induced hyperpolarization, though the response appeared to be smaller than that in normal medium. Neither nicotinic (dimethyl-4-phenyl-piperazinium (DMPP), phenyltrimethylammonium (PTMA) and nicotine) nor muscarinic (muscarine, methacholine, bethanechol and oxotremorine) agonists induced the membrane hyperpolarization, but the former drugs inhibited the IPSPs while the latter drugs did not. Both d-tubocurarine and atropine inhibited the IPSP, but the d-tubocurarine was more potent, causing inhibition even at a dose of 0.5 microM while 2 microM or more atropine was needed. The ACh- or CCh-induced hyperpolarization was inhibited completely by d-tubocurarine (5 microM), but only slightly by atropine (5 microM). These results may indicate that the IPSP and the effects of ACh or CCh are based on a direct interaction between ACh or CCh and ACh receptors on the hair cells.
authors.affiliation: Department of Physiology, Kanazawa Medical University, Ishikawa, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Sugai
authors.forename: J
authors.initials: J
authors.lastname: Yano
authors.forename: M
authors.initials: M
authors.lastname: Sugitani
authors.forename: H
authors.initials: H
authors.lastname: Ooyama
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004525:Efferent Pathways; D004558:Electric Stimulation; D004848:Epithelium / Q000187:drug effects; D006198:Hair Cells, Auditory / Q000187:drug effects / Q000502:physiology*; D008564:Membrane Potentials / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011892:Rana catesbeiana; D012444:Saccule and Utricle / Q000187:drug effects / Q000294:innervation*; D013569:Synapses / Q000187:drug effects; D014403:Tubocurarine / Q000494:pharmacology
chemical_list: D010276:Parasympatholytics; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; C009571:phenyltrimethylammonium; D004246:Dimethylphenylpiperazinium Iodide; D001285:Atropine; D002217:Carbachol; D000109:Acetylcholine; D014403:Tubocurarine